A carregar...

Bevacizumab Monotherapy as Salvage Therapy for Advanced clear cell Renal Cell Carcinoma (ccRCC) Pretreated with Targeted Drugs

Bevacizumab has shown benefit in the first line setting in combination with interferon; however, data on use as monotherapy are limited. This retrospective analysis of 71 patients assesses the efficacy of bevacizumab monotherapy in patients who progressed on other targeted drugs. Bevacizumab monothe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Genitourin Cancer
Main Authors: Lee, Chung-Han, Hötker, Andreas M., Voss, Martin H., Feldman, Darren R., Woo, Kaitlin M., Patil, Sujata, Coskey, Devyn T., Akin, Oguz, Hsieh, James J., Motzer, Robert J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4965701/
https://ncbi.nlm.nih.gov/pubmed/26404107
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2015.07.010
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!